FDA Clearance Tracker · P040029-S009
Euclid Systems Orthokeratology (tisilfocon A) Contact Lenses for Overnight Wear
Last checked: Nov 20, 2026Latest source record: Oct 24, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Oct 24, 2019
Approved
Time to decision
120 days
Received Jun 26, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P040029-S009
- Device name
- Euclid Systems Orthokeratology (tisilfocon A) Contact Lenses for Overnight Wear
- Applicant
- Euclid Vision Corporation
- Applicant location
- Sterling, VA
- Received
- Jun 26, 2019
- Decided
- Oct 24, 2019
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P040029
Device type
- Device class
- Class III
- Regulation
- 21 CFR 886.5916
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for the addition of an alternate lens blank supplier, with a change to the contact angle specification, for the manufacture of the Euclid Systems Orthokeratology (tisilfocon A) Contact Lenses for Overnight Wear.
Source documents
Other decisions for Euclid Vision Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.